Free Trial

VolitionRx (VNRX) SEC Filings & 10K Form

VolitionRx logo
$0.65 +0.06 (+10.53%)
(As of 01:14 PM ET)

Recent VolitionRx SEC Filings

DateFilerForm TypeView
12/09/2024
4:11 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:02 AM
VolitionRx (Filer)
Form 424B5
11/14/2024
3:24 PM
VolitionRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:23 PM
STILL TIMOTHY I (Reporting)
VolitionRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/30/2024
3:38 PM
Rubin Ethel (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:21 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:29 PM
Rubin Ethel (Reporting)
VolitionRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2024
3:01 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
7:26 AM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:17 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
8:51 AM
VolitionRx (Filer)
Form 424B5
07/24/2024
3:06 PM
VolitionRx (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/05/2024
3:05 PM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
8:00 AM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
8:24 AM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
11:15 PM
VolitionRx (Filer)
Form EFFECT
06/25/2024
4:15 PM
VolitionRx (Filer)
Form 424B3
05/24/2024
3:05 PM
Retter Andrew (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:07 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
10:14 AM
VolitionRx (Filer)
Form D
Notice of Exempt Offering of Securities 
03/25/2024
3:19 PM
VolitionRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2024
3:37 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
3:01 PM
Futcher Edward (Reporting)
VolitionRx (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:01 PM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:01 PM
Colman Alan (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Batchelor Ann-Louise (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Hughes Terig (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:03 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:03 PM
Barnes Phillip (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
9:41 AM
Eight Corp Ltd (Reporting)
Hever Investments Ltd (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:00 AM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
9:31 AM
Eight Corp Ltd (Reporting)
Hever Investments Ltd (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
9:59 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
8:38 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:VNRX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners